ADPT's logo.
Ticker Symbol: ADPT

Adaptive Biotechnologies Corp

$32.61 - 20-12-2024 4 p.m. ET

Exchange: NASDAQ Country: US Currency: USD Asset Type: Common Stock CIK:0001478320

Company Profile

we are a commercial-stage, biotechnology organization located in the hot biotech locations of seattle, washington and south san francisco, ca. our world class scientists have invented a patent-pending technology that combines advances in high-throughput sequencing with state-of-the-art computer infrastructure to provide an in-depth analysis of the t- and b-cell repertoire, a specific and important part of the immune system. this information is driving the r&d community to support the fights against cancer, auto-immune disease, and much, much more. we're often asked to describe our company culture. it is very easy ... we're a hard working group of top-notch individuals who are passionate about wanting to make a difference in the world. we know our employees are our most valuable asset, and every employee’s contribution is appreciated. open communication and collaboration are always encouraged in every interaction throughout the organization. we have high expectations of ourselves, and

Sector: Manufacturing
Industry: Biological Product (except Diagnostic) Manufacturing
Standard Industrial Classification Code (SIC code): 2836
Address: 1551 Eastlake Ave E Ste 200
CEO: Chad Robins
Tags:
  • Commercial Services
  • Miscellaneous Commercial Services
  • Manufacturing
  • Biological Product (except Diagnostic) Manufacturing

Pricing

Last Updated: October 20, 2023 03:00 PM EST
Previous Close: $4.12
Change: $0.04 ( 0.98%)
Days Range: $3.94 - $4.17
Beta: 2.58
52wk. High: $10.79
52wk. Low: $3.96
Ytd. Change -45.09%
50 Day Moving Average: $5.36
200 Day Moving Average: $6.76
Shares Outstanding: 144645118

Valuation

Market Cap: 59.6B
PE Ratio: -3.10
EPS (TTM): -1.33

Dividends

Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A